addextherapeuticsadxn)
Addex Therapeutics(ADXN):
Addex Therapeutics(ADXN) 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-23-038581 Act: 34 Size: 15 MB 网页链接
Addex Therapeutics(ADXN):
Addex Therapeutics(ADXN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-041530 Act: 34 Size: 721 KB 网页链接
Addex Therapeutics(ADXN):
Addex Therapeutics(ADXN) SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-040143 Act: 34 Size: 51 KB 网页链接
Addex Therapeutics(ADXN):
Addex Therapeutics(ADXN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-23-001991 Act: 34 Size: 23 KB 网页链接
Addex Therapeutics(ADXN):
Addex Therapeutics(ADXN) 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-23-041624 Act: 33 Size: 1 MB 网页链接
Addex Therapeutics(ADXN):
Addex Therapeutics(ADXN) 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-23-002102 Act: 34 Size: 15 KB 网页链接





